These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 8291455

  • 1. 24-hour serum cortisol profiles in women with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Balint-Perić L.
    Gynecol Endocrinol; 1993 Sep; 7(3):179-84. PubMed ID: 8291455
    [Abstract] [Full Text] [Related]

  • 2. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 3. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N, Cetinozman F, Aksoy DY, Elcin G, Yildiz BO.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [Abstract] [Full Text] [Related]

  • 4. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

  • 5. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, Janowska J, Semik-Grabarczyk E.
    Endokrynol Pol; 2008 Sep; 59(1):13-7. PubMed ID: 18335395
    [Abstract] [Full Text] [Related]

  • 6. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ, Laughlin GA, Bützow T, Maheshwari H, Baumann G, Yen SS.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [Abstract] [Full Text] [Related]

  • 7. The impact of obesity on hormonal parameters in hirsute and nonhirsute women.
    Bernasconi D, Del Monte P, Meozzi M, Randazzo M, Marugo A, Badaracco B, Marugo M.
    Metabolism; 1996 Jan; 45(1):72-5. PubMed ID: 8544780
    [Abstract] [Full Text] [Related]

  • 8. [Insulin resistance and serum concentrations of ovarian and adrenal androgen in obese women without additional disease and with policystic ovary syndrome].
    Olszanecka-Glinianowicz M, Banaś M, Zahorska-Markiewicz B, Kuglin D, Mokrzycka J, Mentel A.
    Endokrynol Pol; 2005 Jan; 56(6):921-6. PubMed ID: 16821212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. GH release after GHRH plus arginine administration in obese and overweight women with polycystic ovary syndrome.
    Orio F, Palomba S, Colao A, Russo T, Dentico C, Tauchmanovà L, Savastano S, Nappi C, Sultan C, Zullo F, Lombardi G.
    J Endocrinol Invest; 2003 Feb; 26(2):117-22. PubMed ID: 12739737
    [Abstract] [Full Text] [Related]

  • 11. Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome.
    Güneş M, Bukan N.
    Gynecol Endocrinol; 2015 Feb; 31(11):903-6. PubMed ID: 26291814
    [Abstract] [Full Text] [Related]

  • 12. Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
    Mejia-Montilla J, Álvarez-Mon M, Reyna-Villasmil E, Torres-Cepeda D, Santos-Bolívar J, Reyna-Villasmil N, Suarez-Torres I, Bravo-Henríquez A.
    Endocrinol Nutr; 2015 Jan; 62(1):31-7. PubMed ID: 25458401
    [Abstract] [Full Text] [Related]

  • 13. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):159-65. PubMed ID: 7554310
    [Abstract] [Full Text] [Related]

  • 14. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK, Goharian LG, Dietze T, Tauchert S, Rudolf S, Diedrich K, Schweiger U, Oltmanns KM.
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [Abstract] [Full Text] [Related]

  • 15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 16. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases.
    Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Franks S.
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):213-20. PubMed ID: 2112067
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.
    Chapman IM, Wittert GA, Norman RJ.
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):175-81. PubMed ID: 9135699
    [Abstract] [Full Text] [Related]

  • 19. Cortisol production rate is similarly elevated in obese women with or without the polycystic ovary syndrome.
    Roelfsema F, Kok P, Pereira AM, Pijl H.
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3318-24. PubMed ID: 20410226
    [Abstract] [Full Text] [Related]

  • 20. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.